Clinical Trial Update: Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial in children aged 4 to 11 comparing an investigational nasal aerosol to placebo for perennial allergic rhinitis; trial completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Investigational nasal aerosol (Teva)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2015-10-12